BACKGROUND: Sepsis and endotoxemia are associated with increased production of interleukin-6 (IL-6) in gut mucosa. Mucosal IL-6 may regulate enterocyte acute phase protein synthesis and intestinal IgA production. In addition, increased IL-6 has been proposed to be a mechanism of loss of mucosal integrity in critical illness. The purpose of this review is to describe current knowledge of the regulation of IL-6 production in the enterocyte/mucosa during inflammation caused by sepsis and endotoxemia. DATA SOURCES: Recent publications describing the influence of sepsis, endotoxemia, and proinflammatory cytokines on mucosal/enterocyte IL-6 production. CONCLUSIONS: IL-6 production is increased in gut mucosa during sepsis and endotoxemia and in cultured enterocytes after treatment with endotoxin or proinflammatory cytokines. The IL-6 gene is regulated by multiple transcription factors, including NF-kappaB, AP-1, and C/EBP. Because of the multiple important biological roles of IL-6, understanding the cellular and molecular mechanisms of mucosal/enterocyte IL-6 production as well as methods to modulate IL-6 production is of clinical importance in the setting of sepsis and other critical illness.
BACKGROUND:Sepsis and endotoxemia are associated with increased production of interleukin-6 (IL-6) in gut mucosa. MucosalIL-6 may regulate enterocyte acute phase protein synthesis and intestinal IgA production. In addition, increased IL-6 has been proposed to be a mechanism of loss of mucosal integrity in critical illness. The purpose of this review is to describe current knowledge of the regulation of IL-6 production in the enterocyte/mucosa during inflammation caused by sepsis and endotoxemia. DATA SOURCES: Recent publications describing the influence of sepsis, endotoxemia, and proinflammatory cytokines on mucosal/enterocyte IL-6 production. CONCLUSIONS:IL-6 production is increased in gut mucosa during sepsis and endotoxemia and in cultured enterocytes after treatment with endotoxin or proinflammatory cytokines. The IL-6 gene is regulated by multiple transcription factors, including NF-kappaB, AP-1, and C/EBP. Because of the multiple important biological roles of IL-6, understanding the cellular and molecular mechanisms of mucosal/enterocyte IL-6 production as well as methods to modulate IL-6 production is of clinical importance in the setting of sepsis and other critical illness.
Authors: Nathan L Huber; Stephanie R Bailey; Rebecca Schuster; Cora K Ogle; Alex B Lentsch; Timothy A Pritts Journal: J Burn Care Res Date: 2012 Mar-Apr Impact factor: 1.845
Authors: Francis Girard; Isabelle P Oswald; Ionélia Taranu; Pierre Hélie; Greg D Appleyard; Josée Harel; John M Fairbrother Journal: Infect Immun Date: 2005-09 Impact factor: 3.441
Authors: Rami Namas; Ruben Zamora; Rajaie Namas; Gary An; John Doyle; Thomas E Dick; Frank J Jacono; Ioannis P Androulakis; Gary F Nieman; Steve Chang; Timothy R Billiar; John A Kellum; Derek C Angus; Yoram Vodovotz Journal: J Crit Care Date: 2011-07-27 Impact factor: 3.425
Authors: Kazuyuki Kitatani; Kely Sheldon; Viviana Anelli; Russell W Jenkins; Ying Sun; Gregory A Grabowski; Lina M Obeid; Yusuf A Hannun Journal: J Biol Chem Date: 2009-03-11 Impact factor: 5.157
Authors: Kenichiro Maeda; Alex Malykhin; Brittany N Teague-Weber; Xiao-Hong Sun; A Darise Farris; K Mark Coggeshall Journal: Blood Date: 2009-02-17 Impact factor: 22.113